Gheuens Sarah sold AGIO
July 9, 2025 · Form 4 insider transaction
Gheuens Sarah sold 847 shares of Agios Pharmaceuticals, Inc. at $38.76 per share, a transaction worth $32.8K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Footnotes
This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.; The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $38.55 to $38.87. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.